Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Hunt

Showing results (961-970 of 1,059) with videos related to

Pageof 106
Sort By:
Annals of Surgical Oncology|October 31, 2006
Surgical resection of gastrointestinal stromal tumors after treatment with imatinibRobert H I Andtbacka, Chaan S Ng, Courtney L Scaife, et al.
Breast Cancer Research and Treatment|March 7, 2012
Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body massHenry M Kuerer, Sara A Lari, Banu K Arun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapyH M Kuerer, L A Newman, T L Smith, et al.
Journal of Counseling Psychology|December 28, 2018
Social cognitive predictors of engineering students' academic persistence intentions, satisfaction, and engagementRachel L Navarro, Lisa Y Flores, John-Paul Legerski, et al.
Annals of Surgical Oncology|February 1, 2023
Practice Pattern Variability in the Management of Regional Lymph Node Metastasis in Extremity and Trunk Soft Tissue Sarcoma: A Survey of the Society of Surgical Oncology and Musculoskeletal Tumor Society MembershipRussell G Witt, Rachel K Voss, Yi-Ju Chiang, et al.
Cancer|February 6, 2003
Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapyFunda Meric, Nadeem Q Mirza, Georges Vlastos, et al.
Cancer|September 21, 2004
The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancerJennifer F Tseng, Steven J Kronowitz, Charlotte C Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized study population and data of additional patients treated with the same regimenAman U Buzdar, Vicente Valero, Nuhad K Ibrahim, et al.
Cancer Research|August 26, 2024
Low-Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast CancerMi Li, Amriti R Lulla, Yan Wang, et al.
Pediatric Blood & Cancer|April 1, 2018
Phase I trial of the mTOR inhibitor everolimus in combination with multi-agent chemotherapy in relapsed childhood acute lymphoblastic leukemiaAndrew E Place, Yana Pikman, Kristen E Stevenson, et al.
Pageof 106

Showing results (961-970 of 1,059) with videos related to

Sort By:
Pageof 106
Annals of Surgical Oncology|October 31, 2006
Surgical resection of gastrointestinal stromal tumors after treatment with imatinibRobert H I Andtbacka, Chaan S Ng, Courtney L Scaife, et al.
Breast Cancer Research and Treatment|March 7, 2012
Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body massHenry M Kuerer, Sara A Lari, Banu K Arun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapyH M Kuerer, L A Newman, T L Smith, et al.
Journal of Counseling Psychology|December 28, 2018
Social cognitive predictors of engineering students' academic persistence intentions, satisfaction, and engagementRachel L Navarro, Lisa Y Flores, John-Paul Legerski, et al.
Annals of Surgical Oncology|February 1, 2023
Practice Pattern Variability in the Management of Regional Lymph Node Metastasis in Extremity and Trunk Soft Tissue Sarcoma: A Survey of the Society of Surgical Oncology and Musculoskeletal Tumor Society MembershipRussell G Witt, Rachel K Voss, Yi-Ju Chiang, et al.
Cancer|February 6, 2003
Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapyFunda Meric, Nadeem Q Mirza, Georges Vlastos, et al.
Cancer|September 21, 2004
The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancerJennifer F Tseng, Steven J Kronowitz, Charlotte C Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized study population and data of additional patients treated with the same regimenAman U Buzdar, Vicente Valero, Nuhad K Ibrahim, et al.
Cancer Research|August 26, 2024
Low-Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast CancerMi Li, Amriti R Lulla, Yan Wang, et al.
Pediatric Blood & Cancer|April 1, 2018
Phase I trial of the mTOR inhibitor everolimus in combination with multi-agent chemotherapy in relapsed childhood acute lymphoblastic leukemiaAndrew E Place, Yana Pikman, Kristen E Stevenson, et al.
Pageof 106